Related Experiment Videos

Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes

E Prina1, C Jouanne, S de Souza Lão

  • 1Unité d'Immunophysiologie Cellulaire, Institut Pasteur, Paris, France.

Insights

Leishmania-infected macrophages show impaired antigen presentation to T cells. This dysfunction, observed in both infected and treated cells, suggests interference with antigen processing or competition for MHC molecules.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Macrophages (M phi) infected with Leishmania are investigated for their antigen-presenting capabilities.
  • Leishmania-specific CD4+ T lymphocytes rely on antigen presentation by infected cells.

Purpose of the Study:

  • To assess the antigen-presenting cell (APC) function of Leishmania-infected bone marrow-derived macrophages.
  • To determine the ability of infected macrophages to stimulate Leishmania-specific CD4+ T-cell hybridomas.

Main Methods:

  • Bone marrow-derived macrophages infected with Leishmania amazonensis amastigotes were used.
  • T-cell hybridomas specific for bacteriophage lambda repressor cl protein, human chorionic gonadotropin, or OVA were employed.
  • Antigen presentation capacity, MHC (la) molecule expression, and peptide binding were analyzed.

Main Results:

  • Infected macrophages exhibited reduced capacity to present native antigens to most T-cell hybridomas.
  • No significant differences in MHC (la) expression or peptide-binding ability were found between infected and uninfected macrophages.
  • Both infected and cured macrophages, as well as those exposed to parasite components, showed impaired antigen presentation.

Conclusions:

  • The functional failure in antigen presentation by Leishmania-infected macrophages is likely due to interference with MHC-peptide complex formation or competition for MHC binding.
  • These findings suggest a novel mechanism of immune evasion by Leishmania parasites.

Related Concept Videos